epigenetic reprogramming
2 stories
-
healthLife Biosciences Administers First Human Gene Therapy to Reverse Cellular Aging
Boston-based Life Biosciences has initiated the first human trial of ER-100, a gene therapy using OSK factors to rejuvenate cells and treat optic neuropathies like glaucoma.
-
healthCoinbase CEO's Biotech Startup NewLimit Hits $3.1B Valuation
NewLimit, co-founded by Brian Armstrong, triples valuation to $3.1B after raising $435M to develop cellular reprogramming therapies for age-related diseases.